Page last updated: 2024-11-13

estradiol benzoate, progesterone drug combination

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

estradiol benzoate, progesterone drug combination: contains estradiol benzoate & progesterone [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID56840923
SCHEMBL ID21799256
MeSH IDM0084620

Synonyms (19)

Synonym
duogynon
limovanil
duogynon forte
duogynon simplex
estradiol benzoate, progesterone drug combination
jephagynon
synovex c
tonevex s
implus s
menstrogen forte
klimovan
synovex-s
estradiol benzoate - progesterone
implus-c
estroprogyn
estradiol benzoate-progesterone mixt.
8000-03-1
DTXSID20229998
SCHEMBL21799256

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
"To assess the acute and chronic dose-response effects of flibanserin on measures of sexual desire and copulation in ovariectomized rats primed with estradiol benzoate (EB) alone or in combination with progesterone (P)."( Flibanserin treatment increases appetitive sexual motivation in the female rat.
Allers, KA; Gelez, H; Giuliano, F; Greggain-Mohr, J; Pfaus, JG, 2013
)
0.39
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (45)

TimeframeStudies, This Drug (%)All Drugs %
pre-19909 (20.00)18.7374
1990's21 (46.67)18.2507
2000's8 (17.78)29.6817
2010's7 (15.56)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.70

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.70 (24.57)
Research Supply Index3.93 (2.92)
Research Growth Index4.63 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.70)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials4 (8.70%)5.53%
Reviews0 (0.00%)6.00%
Case Studies2 (4.35%)4.05%
Observational0 (0.00%)0.25%
Other40 (86.96%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]